SCHEMBL2007642

SCHEMBL2007642

COc1ccc(S(=O)(=O)n2cc(C)c3cc(F)ccc32)cc1NCCCN(C)C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.60
HTR6 P50406 17/20 0.54
DRD2 P14416 2/20 0.47
HTR7 P34969 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
SLC6A4 P31645 1/20 0.47
HRH1 P35367 1/20 0.47
ADRA1B P35368 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR1E P28566 1/20 0.40
HTR1F P30939 1/20 0.40
DRD3 P35462 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2007319 0.95 KCNH2 (0.62) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2012145 0.91 HTR6 (0.54) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2005926 0.89 DRD2 (0.60) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2008366 0.89 HTR6 (0.54) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2008527 0.88 HTR6 (0.48) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2006044 0.86 HTR6 (0.55) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2314849 0.84 HTR6 (0.56) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2005725 0.84 KCNH2 (0.62) KCNH2HTR6DRD2HTR7CYP3A4
SCHEMBL2006399 0.83 HTR6 (0.56) HTR6DRD2HTR7HTR1AHTR1D
SCHEMBL2013322 0.82 HTR6 (0.49) KCNH2HTR6DRD2HTR7CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200980-B9 AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS FIELD OF INVENTION SUVEN LIFE SCIENCES LTD (IN) 2011-12-28 EP claimed
EP-2200980-B1 AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS FIELD OF INVENTION SUVEN LIFE SCIENCES LTD (IN) 2011-08-03 EP claimed
US-7964627-B2 Amino arylsulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-06-21 US claimed
US-20100216861-A1 AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-08-26 US claimed
EP-2200980-B9 AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS FIELD OF INVENTION SUVEN LIFE SCIENCES LTD (IN) 2011-12-28 EP disclosed
EP-2200980-B1 AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS FIELD OF INVENTION SUVEN LIFE SCIENCES LTD (IN) 2011-08-03 EP disclosed
US-7964627-B2 Amino arylsulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-06-21 US disclosed
US-20100216861-A1 AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216861-A1 AMINO ARYLSULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS HTR6, HTR5A, HTR1A KCNH2 1645/4885HTR6 1/4885DRD2 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.